Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: KAR-5585
  • Price: $990.0/100mg $1600.0/250mg $3300.0/1g $150.0/10ml
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1673571-51-1

1673571-51-1 structure
1673571-51-1 structure
  • Name: KAR-5585
  • Chemical Name: Rodatristat ethyl
  • CAS Number: 1673571-51-1
  • Molecular Formula: C29H31ClF3N5O3
  • Molecular Weight: 590.04
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease Tryptophan Hydroxylase
  • Create Date: 2019-10-07 20:30:52
  • Modify Date: 2024-01-08 18:57:46
  • Rodatristat ethyl (KAR5585) is an orally active tryptophan hydroxylase 1 (TPH1) inhibitor with nanomolar in vitro potency. Rodatristat ethyl reduces the level of 5-HT and significantly reduces pulmonary arterial hypertension (PAH)[1][2].

Name Rodatristat ethyl
Description Rodatristat ethyl (KAR5585) is an orally active tryptophan hydroxylase 1 (TPH1) inhibitor with nanomolar in vitro potency. Rodatristat ethyl reduces the level of 5-HT and significantly reduces pulmonary arterial hypertension (PAH)[1][2].
Related Catalog
In Vivo Rodatristat ethyl (100 or 200 mg/kg; oral administration; once daily; for 28 days; male Sprague-Dawley rats) treatment decreases erum, gut and lung 5-HT levels in a dose-dependent manner and significantly reduces pulmonary arterial pressure, and pulmonary vessel wall thickness and occlusion in male rats with monocrotaline (MCT)[1]. Animal Model: Male Sprague-Dawley rats (175-200 g)[1] Dosage: 100 mg/kg or 200 mg/kg Administration: Oral administration; once daily; for 28 days Result: Decreased serum, gut and lung 5-HT levels in a dose-dependent manner and significantly reduced pulmonary arterial pressure, and pulmonary vessel wall thickness and occlusion in male rats.
References

[1]. Aiello RJ, et al. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Modelsof Pulmonary Hypertension. J Pharmacol Exp Ther. 2017 Feb;360(2):267-279.

[2]. Alice Melão, MSc. Early Results on Rodatristat Ethyl Support Launch of Phase 2 Trial in PAH Patients. FEBRUARY 4, 2019.

Molecular Formula C29H31ClF3N5O3
Molecular Weight 590.04